NO952748L - Polypeptid som spesifikt inhiberer Cathepsin L. - Google Patents

Polypeptid som spesifikt inhiberer Cathepsin L.

Info

Publication number
NO952748L
NO952748L NO952748A NO952748A NO952748L NO 952748 L NO952748 L NO 952748L NO 952748 A NO952748 A NO 952748A NO 952748 A NO952748 A NO 952748A NO 952748 L NO952748 L NO 952748L
Authority
NO
Norway
Prior art keywords
polypeptide
cathepsin
osteoporosis
specifically inhibits
well
Prior art date
Application number
NO952748A
Other languages
English (en)
Norwegian (no)
Other versions
NO952748D0 (no
Inventor
Nobuhiko Katsunuma
Vito Turk
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of NO952748D0 publication Critical patent/NO952748D0/no
Publication of NO952748L publication Critical patent/NO952748L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO952748A 1993-11-12 1995-07-11 Polypeptid som spesifikt inhiberer Cathepsin L. NO952748L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28327093 1993-11-12
JP31353393A JP3276753B2 (ja) 1993-11-12 1993-12-14 カテプシンl特異的阻害ポリペプチド
PCT/JP1994/001878 WO1995013302A1 (en) 1993-11-12 1994-11-08 Cathepsin-l-specific inhibitor polypeptide

Publications (2)

Publication Number Publication Date
NO952748D0 NO952748D0 (no) 1995-07-11
NO952748L true NO952748L (no) 1995-07-11

Family

ID=26554960

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952748A NO952748L (no) 1993-11-12 1995-07-11 Polypeptid som spesifikt inhiberer Cathepsin L.

Country Status (11)

Country Link
US (1) US5698519A (de)
EP (1) EP0679659B1 (de)
JP (1) JP3276753B2 (de)
KR (1) KR950704358A (de)
AT (1) ATE178909T1 (de)
AU (1) AU671783B2 (de)
CA (1) CA2151059A1 (de)
DE (1) DE69417872T2 (de)
HU (1) HU214343B (de)
NO (1) NO952748L (de)
WO (1) WO1995013302A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481489A1 (en) * 2002-11-29 2004-06-17 Morinaga Milk Industry Co., Ltd. Cysteine protease inhibitor
WO2004084830A2 (en) * 2003-03-21 2004-10-07 Buck Institute Method for treating alzheimer’s dementia
US20070203073A1 (en) * 2005-06-22 2007-08-30 Diamond Scott L SARS and Ebola inhibitors and use thereof, and methods for their discovery
WO2008112917A2 (en) * 2007-03-13 2008-09-18 Uti Limited Partnership Peptidyl fluoromethylketones as inhibitors of viral replication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3938971A1 (de) * 1989-11-24 1991-05-29 Biotechnolog Forschung Gmbh Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat

Also Published As

Publication number Publication date
ATE178909T1 (de) 1999-04-15
WO1995013302A1 (en) 1995-05-18
DE69417872D1 (en) 1999-05-20
HU214343B (hu) 1998-03-02
AU8067494A (en) 1995-05-29
JP3276753B2 (ja) 2002-04-22
NO952748D0 (no) 1995-07-11
JPH07179496A (ja) 1995-07-18
EP0679659A4 (de) 1996-05-22
HUT73415A (en) 1996-07-29
EP0679659B1 (de) 1999-04-14
KR950704358A (ko) 1995-11-20
HU9501580D0 (en) 1995-09-28
DE69417872T2 (de) 1999-08-12
EP0679659A1 (de) 1995-11-02
US5698519A (en) 1997-12-16
CA2151059A1 (en) 1995-05-18
AU671783B2 (en) 1996-09-05

Similar Documents

Publication Publication Date Title
NO20092860L (no) 2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
NO20006718L (no) Proteaseinhibitorer
TW261608B (de)
DE69634678D1 (de) Verbesserung oder heilung von durch ischämischen krankheiten hervorgerufenen symtomen und dafür verwendbare phenylpiperidinverbingungen
NZ248377A (en) Use of interleukin-1 beta protease and interleukin-1 beta protease inhibitors
AP9200410A0 (en) Retroviral protease inhibitors.
ATE245977T1 (de) Therapeutische substituierte guanidine
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
BR9809306A (pt) Inibidores de protease
ITFI920078A0 (it) Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umana.
EP0985671A4 (de) PYRIDOCARBAZOL DERIVATE DIE EINEN cGMP-PDE INHIBILIERENDEN EFFEKT HABEN
ATE245447T1 (de) Inhibitor von gehirnödemen
ATE181336T1 (de) Die knochenresorption hemmende verbindungen und zusammensetzungen
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
AU671783B2 (en) Cathepsin-L-specific inhibitor polypeptide
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
EP0355409A3 (de) Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS
ES2119746T3 (es) Nuevo peptido fisiologicamente activo y agente regulador del metabolismo del calcio que comprende dicho peptido como ingrediente activo.
DK0826373T3 (da) Forebyggende middel mod postoperativ astigmatisme
UY25369A1 (es) Procedimiento para preparar inhibidores de proteasa
GEP19991605B (en) Inhibitor, Its Obtaining and Use